 | Up a level |
Journal Article
Ceccon, G. S., Werner, J., Ruge, M., I, Goldbrunner, R., Celik, E., Baues, C., Deckert, M., Brunn, A., Buttner, R., Golla, H., Nogova, L., Schlamann, M., Kabbasch, C., Ruess, D., Hampl, J., Wollring, M., Bauer, E. K., Tscherpel, C., Fink, G. R., Langen, K. and Galldiks, N. (2022). Impact of FET PET on multidisciplinary neurooncological tumor board decisions in patients with brain tumors. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Lohmann, P., Kocher, M., Ceccon, G., Bauer, E. K., Stoffels, G., Viswanathan, S., Ruge, M. I., Neumaier, B., Shah, N. J., Fink, G. R., Langen, K. and Galldiks, N. (2018). COMBINED FET PET/MRI RADIOMICS FOR THE DIFFERENTIATION OF RADIATION INJURY FROM RECURRENT BRAIN METASTASIS. Neuro-Oncology, 20. S. 304 - 305. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Lohmann, P., Stavrinou, P., Lipke, K., Bauer, E. K., Ceccon, G., Werner, J., Fink, G. R., Shah, N. J., Langen, K. and Galldiks, N. (2018). SPATIAL CORRELATION OF FET UPTAKE AND MRI CONTRAST ENHANCEMENT IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS PRIOR TO TREATMENT. Neuro-Oncology, 20. S. 231 - 232. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Werner, J., Wolf, L., Tscherpel, C., Bauer, E. K., Wollring, M., Ceccon, G., Deckert, M., Brunn, A., Pappesch, R., Goldbrunner, R., Fink, G. R. and Galldiks, N. (2022). EFFICACY AND TOLERABILITY OF REGORAFENIB IN PRETREATED PATIENTS WITH PROGRESSIVE CNS GRADE 3 OR 4 GLIOMAS. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866
Wollring, M. M., Werner, J., Bauer, E. K., Tscherpel, C., Lohmann, P., Kabbasch, C., Goldbrunner, R., Fink, G. R., Langen, K. J. and Galldiks, N. (2022). PREDICTION OF RESPONSE TO LOMUSTINE-BASED CHEMOTHERAPY IN GLIOMA PATIENTS AT RELAPSE USING MRI AND FET PET. Neuro-Oncology, 24. CARY: OXFORD UNIV PRESS INC. ISSN 1523-5866